Retinitis Pigmentosa: Advanced Imaging Biomarkers
On April 21, join us online for an insightful discussion with a panel of experts in ophthalmology, inherited retinal diseases (IRDs), advanced retinal imaging and AI-driven retinal image analysis.
You will discover how cellular-level retinal imaging biomarkers already open new avenues for natural history studies and clinical trials in retinitis pigmentosa (RP).
Dr. Akiko Maeda, Dr. Kiyoko Gocho and Prof. Danilo Andrade De Jesus will share their insight and vision, based on their experience with Imagine Eyes’ rtx1 devices.
Which biomarkers are relevant to your research on retinitis pigmentosa, and how can you implement them? Bring your questions to the interactive Q&A session!
Please register to join the live session
About our guests
Akiko Maeda, MD, PhD, is the deputy director of the Research Center at Kobe City Eye Hospital, and a visiting professor at Ritsumeikan University and Case Western Reserve University. She graduated from Sapporo Medical University in 1996 and earned her PhD in ophthalmology and pathology in 2001. Following postdoctoral training at the University of Washington and Case Western Reserve University, Dr. Maeda joined the faculty in the Department of Ophthalmology at Case Western Reserve University. Since returning to Japan, Dr. Maeda has led retinal degeneration research at the RIKEN Center and Kobe City Eye Hospital. Currently, she provides patient care in the inherited retinal degeneration (IRD) clinic while advancing translational research to bring gene and cell therapy closer to clinical applications. This research includes investigating advanced imaging biomarkers for IRDs.
Danilo Andrade de Jesus, PhD, is an assistant professor and the principal investigator at the Eye Image Analysis Group (EyeR), a joint collaboration between Erasmus Medical Center and the Rotterdam Eye Hospital in The Netherlands. With a PhD in Biomedical Engineering and over several years of experience, Dr. Andrade specialized in image processing and AI applied to ophthalmology. His scientific contributions include new methods for analyzing adaptive optics (AO), OCT, and OCTA imaging applied to various diseases, including glaucoma and inherited retinal diseases (IRDs). Dr. Andrade has actively participated in and contributed to multiple collaborative projects, highlighting his dedication to advancing ophthalmic image analysis and understanding diseases that affect the eye. He currently co-leads the AO-Vision project, which focuses on developing AO imaging biomarkers for IRDs.
Kiyoko Gocho, MD, PhD, is a researcher at Paris Eye Imaging and Clinical Investigation Center 1423, Quinze-Vingts National Ophthalmology Hospital in Paris, France. Previously, she served as an associate professor of ophthalmology at the Nippon Medical School and as a visiting ophthalmologist at the Kobe Eye Center in Japan. Dr. Gocho completed her PhD at Akita University in 2001, where she began her career as assistant professor of ophthalmology. She is a highly sought-after ophthalmic clinician and surgeon, recognized for her managerial and teaching skills. Dr. Gocho has dedicated her research to translating cellular-resolution retinal imaging techniques from laboratory inception to clinical adoption. Since relocating to France, she has organized joint research projects with the Kobe Eye Center and the University of Pittsburgh, involving AO imaging for IRDs and AMD. Dr. Gocho is committed to improving both the prevention of diseases and the personalization of therapies.
